David Fredrickson

Biography

Skills and experience: Dave Fredrickson was appointed EVP, Global Head Oncology Business Unit in October 2017 and is responsible for driving growth and maximizing commercial performance of the global oncology and hematology portfolio within AstraZeneca. In addition, he plays a critical leadership role in setting the Oncology portfolio and product strategy for the organisation. Prior to this role, Dave served as President of AstraZeneca K.K. in Japan, and Vice President, Specialty Care for AstraZeneca in the United States, spanning oncology, infection disease, and neuroscience medicines. Dave joined AstraZeneca from Roche/Genentech in 2014, where he was Business Unit Manager, Oncology in Spain and held growing commercial responsibilities in strategy, marketing and sales in the US.  He also served for nine years at the Monitor Group, LLC (now Monitor Deloitte Group, LLC), a global strategy consultancy. He has served as Vice Chairman of European Federation of Pharmaceutical Industries and Associations (EFPIA) Japan and was a member of the Board of the Japan Pharmaceutical Manufacturers Association (JPMA).  He is a graduate of Georgetown University (DC) in Government.

Research Interest

BIOCHEMISTRY